Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | solute carrier family 22 (organic anion/urate transporter), member 12 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | major facilitator superfamily protein | solute carrier family 22 (organic anion/urate transporter), member 12 | 519 aa | 541 aa | 26.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | tubulin subunit beta | 0.0027 | 0.5 | 0.5 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.0027 | 0.5 | 0.5 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0027 | 0.5 | 0.5 |
Schistosoma mansoni | tubulin subunit beta | 0.0027 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0027 | 0.5 | 0.5 |
Trichomonas vaginalis | tubulin alpha chain, putative | 0.0027 | 0.5 | 0.5 |
Loa Loa (eye worm) | tubulin beta-4 chain | 0.0027 | 0.5 | 0.5 |
Loa Loa (eye worm) | tubulin beta-2A chain | 0.0027 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0027 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0027 | 0.5 | 0.5 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0027 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0027 | 0.5 | 0.5 |
Trypanosoma brucei | beta tubulin | 0.0027 | 0.5 | 0.5 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0027 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0027 | 0.5 | 0.5 |
Echinococcus granulosus | tubulin beta 4A class IVa | 0.0027 | 0.5 | 0.5 |
Trichomonas vaginalis | tubulin gamma chain, putative | 0.0027 | 0.5 | 0.5 |
Loa Loa (eye worm) | beta-tubulin | 0.0027 | 0.5 | 0.5 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0027 | 0.5 | 0.5 |
Loa Loa (eye worm) | tubulin beta-1 chain | 0.0027 | 0.5 | 0.5 |
Schistosoma mansoni | tubulin subunit beta | 0.0027 | 0.5 | 0.5 |
Entamoeba histolytica | tubulin family protein | 0.0027 | 0.5 | 0.5 |
Schistosoma mansoni | tubulin subunit beta | 0.0027 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0027 | 0.5 | 0.5 |
Giardia lamblia | Beta tubulin | 0.0027 | 0.5 | 0.5 |
Echinococcus multilocularis | beta tubulin | 0.0027 | 0.5 | 0.5 |
Brugia malayi | beta-tubulin, identical | 0.0027 | 0.5 | 0.5 |
Toxoplasma gondii | beta tubulin | 0.0027 | 0.5 | 0.5 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0027 | 0.5 | 0.5 |
Echinococcus multilocularis | beta tubulin | 0.0027 | 0.5 | 0.5 |
Trichomonas vaginalis | tubulin, putative | 0.0027 | 0.5 | 0.5 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0027 | 0.5 | 0.5 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.0027 | 0.5 | 0.5 |
Plasmodium vivax | tubulin beta chain, putative | 0.0027 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0027 | 0.5 | 0.5 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0027 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0027 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0027 | 0.5 | 0.5 |
Entamoeba histolytica | tubulin family protein | 0.0027 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0027 | 0.5 | 0.5 |
Plasmodium falciparum | tubulin beta chain | 0.0027 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0027 | 0.5 | 0.5 |
Schistosoma mansoni | tubulin subunit beta | 0.0027 | 0.5 | 0.5 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0027 | 0.5 | 0.5 |
Echinococcus multilocularis | tubulin, beta 4A class IVa | 0.0027 | 0.5 | 0.5 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0027 | 0.5 | 0.5 |
Loa Loa (eye worm) | BEN-1 protein | 0.0027 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0027 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0027 | 0.5 | 0.5 |
Giardia lamblia | Beta tubulin | 0.0027 | 0.5 | 0.5 |
Trypanosoma cruzi | beta tubulin, putative | 0.0027 | 0.5 | 0.5 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.0027 | 0.5 | 0.5 |
Schistosoma mansoni | tubulin subunit beta | 0.0027 | 0.5 | 0.5 |
Echinococcus multilocularis | tubulin beta 1 chain | 0.0027 | 0.5 | 0.5 |
Giardia lamblia | Beta tubulin | 0.0027 | 0.5 | 0.5 |
Trypanosoma brucei | beta tubulin | 0.0027 | 0.5 | 0.5 |
Schistosoma mansoni | tubulin subunit beta | 0.0027 | 0.5 | 0.5 |
Echinococcus granulosus | beta tubulin | 0.0027 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0027 | 0.5 | 0.5 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.0027 | 0.5 | 0.5 |
Trypanosoma brucei | beta tubulin | 0.0027 | 0.5 | 0.5 |
Echinococcus granulosus | tubulin beta 1 chain | 0.0027 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0027 | 0.5 | 0.5 |
Toxoplasma gondii | beta-1 tubulin, putative | 0.0027 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0027 | 0.5 | 0.5 |
Echinococcus granulosus | beta tubulin | 0.0027 | 0.5 | 0.5 |
Loa Loa (eye worm) | BEN-1 protein | 0.0027 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0027 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.0027 | 0.5 | 0.5 |
Toxoplasma gondii | beta-tubulin, putative | 0.0027 | 0.5 | 0.5 |
Trypanosoma brucei | beta tubulin | 0.0027 | 0.5 | 0.5 |
Loa Loa (eye worm) | tubulin beta chain | 0.0027 | 0.5 | 0.5 |
Echinococcus granulosus | tubulin subunit beta | 0.0027 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | > 1382 nM | BindingDB_Patents: Inhibition Assay. Assay compound plates were prepared by diluting the compounds of formula (I) with chloride-free buffer (125 mM Na-gluconate, 4.8 mM K-gluconate, 1.3 mM Ca-gluconate, 1.2 mM KH2PO4, 1.2 mM MgSO4, 5.6 mM D-glucose, 25 mM HEPES, pH 7.4 with NaOH) in 100% DMSO to a final concentration of 1% DMSO. [14C]-Uric Uric acid working stock was made by addition of radiolabeled compound to a final concentration of 120 nM in chloride-free buffer. In all wells, the final assay concentration of solvent (DMSO) was 0.25%; the final assay concentration of [14C]-uric acid was 30 nM in chloride-free buffer and the final compound of formula (I) concentrations ranged from 0 to 10 uM. The vehicle comparator was DMSO (i.e. no inhibition of uric acid transport) and the pharmacological blockade (i.e. 100% inhibition of uric acid transport) was defined by benzbromarone at 10 uM final assay concentration.After pre-incubation, cells were washed with 50 uL of chloride-free buffer. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.